Phase II Multicenter Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Toxicity and Outcome
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Treatment related toxicity-free survival
From the date of SBRT to the date of treatment related toxicity or last follow-up; Treatment related toxicity will be evaluated by the following criteria. Adverse events using Common Terminology Criteria for Adverse Events (CTCAE) version 4.0; Classic radiation induced liver disease; Non-classic Classic radiation induced liver disease; Worsening of Child-Turcotte-Pugh score; Worsening of MELD score
1 year
Yes
Mi-Sook Kim, MD, PhD
Principal Investigator
Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Korea: Ministry of Food and Drug Safety
K-1201-001-004
NCT01850667
January 2012
September 2015
Name | Location |
---|